1. 33 Cetuximab paying toll to improve its therapeutic efficacy – Improving cetuximab-mediated head and neck cancer treatment via co-activation of Fc-receptors and toll-like receptors. Issue 5 (May 2015) Authors: Ganzevles, S.; Tuk, K.; van Egmond, M.; Leemans, C.R.; Braakhuis, B.J.M.; Brakenhoff, R.H. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 33 Cetuximab paying toll to improve its therapeutic efficacy – Improving cetuximab-mediated head and neck cancer treatment via co-activation of Fc-receptors and toll-like receptors. Issue 5 (May 2015) Authors: Bakema, J.; Ganzevles, S.; Tuk, K.; van Egmond, M.; Leemans, C.R.; Braakhuis, B.J.M.; Brakenhoff, R.H. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 33 Cetuximab paying toll to improve its therapeutic efficacy – Improving cetuximab-mediated head and neck cancer treatment via co-activation of Fc-receptors and toll-like receptors. Issue 5 (May 2015) Authors: Bakema, J.; Ganzevles, S.; Tuk, K.; van Egmond, M.; Leemans, C.R.; Braakhuis, B.J.M.; Brakenhoff, R.H. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗